Why Cloudflare Stock Slumped Nearly 15% This Week
It could be interest rates, political turmoil, or just a breather from yet another fantastic year for this high-flying stock.
Mindfully Curated
It could be interest rates, political turmoil, or just a breather from yet another fantastic year for this high-flying stock.
A Wall Street analyst sees upside from here for the airlines.
The SPAC stock just filed a prospectus to sell 80 million shares.
Redfin and AMD represent two best-in-class opportunities in two red-hot industries.
These outstanding companies have been winning for a long time, and you can get their stock at a discount right now.
Finding bargains in the market is a rarity these days, so you should load up on shares of these businesses if the opportunity presents itself.
A possible oral COVID-19 treatment is weighing on the shares of vaccine markers like Dynavax today.
This high-flying tech stock tumbled for two key reasons.
The market is turning sour on this image-based, social media business — which could be an opportunity.
Retailers are facing increasing headwinds of long lead times, higher input costs, and the recent COVID resurgence.
Merck’s news is great news for the cruise industry today.
The market selling tech and growth stocks this week didn’t help Snap.
These two semiconductor giants announced new partnerships on the same day.
The international pizza chain is thriving during the pandemic, but that will not last forever.
Three stocks growing earnings in very different ways.
The discovery of genes that directly cause obesity could pave the way for treatments for a condition that affects more than 40% of American adults.
Researchers analyzed idle thoughts for 10 minutes. What they learned may be useful in the diagnosis and treatment of mental health issues such as depression.
Researchers have shown that high levels of a specific protein circulating in the blood accurately detect a severe type of peripheral artery disease that narrows the arteries in the legs and can raise the risk of heart attack and stroke.
A COVID-19 pill could be a game changer.
The company looks very similar to Starbucks in its early years. But is it a buy?